339 related articles for article (PubMed ID: 16530171)
21. Opioid activity of spinally selective analogues of N-naphthoyl-β-naltrexamine in HEK-293 cells and mice.
Le Naour M; Lunzer MM; Powers MD; Portoghese PS
J Med Chem; 2012 Jan; 55(2):670-7. PubMed ID: 22136373
[TBL] [Abstract][Full Text] [Related]
22. Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain.
Nation KM; De Felice M; Hernandez PI; Dodick DW; Neugebauer V; Navratilova E; Porreca F
Pain; 2018 May; 159(5):919-928. PubMed ID: 29369967
[TBL] [Abstract][Full Text] [Related]
23. Biasing G
Sanchez GA; Smrcka AV; Jutkiewicz EM
Mol Pharmacol; 2024 Jun; 106(1):47-55. PubMed ID: 38769020
[TBL] [Abstract][Full Text] [Related]
24. Allosteric modulators of the δ GABA
Genaro K; Yoshimura RF; Doan BP; Johnstone TB; Hogenkamp DJ; Gee KW
Neuropharmacology; 2022 Nov; 219():109221. PubMed ID: 36084794
[TBL] [Abstract][Full Text] [Related]
25. Distinct pathways for norepinephrine- and opioid-triggered antinociception from the amygdala.
Maire JJ; Close LN; Heinricher MM; Selden NR
Eur J Pain; 2016 Feb; 20(2):206-14. PubMed ID: 25847835
[TBL] [Abstract][Full Text] [Related]
26. Oligomerization of MrgC11 and μ-opioid receptors in sensory neurons enhances morphine analgesia.
He SQ; Xu Q; Tiwari V; Yang F; Anderson M; Chen Z; Grenald SA; Raja SN; Dong X; Guan Y
Sci Signal; 2018 Jun; 11(535):. PubMed ID: 29921657
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological mechanisms underlying the antinociceptive and tolerance effects of the 6,14-bridged oripavine compound 030418.
Wen Q; Yu G; Li YL; Yan LD; Gong ZH
Acta Pharmacol Sin; 2011 Oct; 32(10):1215-24. PubMed ID: 21863064
[TBL] [Abstract][Full Text] [Related]
28. Broad-spectrum analgesic efficacy of IBNtxA is mediated by exon 11-associated splice variants of the mu-opioid receptor gene.
Wieskopf JS; Pan YX; Marcovitz J; Tuttle AH; Majumdar S; Pidakala J; Pasternak GW; Mogil JS
Pain; 2014 Oct; 155(10):2063-70. PubMed ID: 25093831
[TBL] [Abstract][Full Text] [Related]
29. In Vitro and In Vivo Pharmacological Profiles of LENART01, a Dermorphin-Ranatensin Hybrid Peptide.
Hochrainer N; Serafin P; D'Ingiullo S; Mollica A; Granica S; Brytan M; Kleczkowska P; Spetea M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612817
[TBL] [Abstract][Full Text] [Related]
30. Determination of μ-, δ- and κ-opioid receptors in forebrain cortex of rats exposed to morphine for 10 days: Comparison with animals after 20 days of morphine withdrawal.
Ujcikova H; Hlouskova M; Cechova K; Stolarova K; Roubalova L; Svoboda P
PLoS One; 2017; 12(10):e0186797. PubMed ID: 29053731
[TBL] [Abstract][Full Text] [Related]
31. Effects of ketoprofen, morphine, and kappa opioids on pain-related depression of nesting in mice.
Negus SS; Neddenriep B; Altarifi AA; Carroll FI; Leitl MD; Miller LL
Pain; 2015 Jun; 156(6):1153-1160. PubMed ID: 25827812
[TBL] [Abstract][Full Text] [Related]
32. Selective κ receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice.
Spetea M; Eans SO; Ganno ML; Lantero A; Mairegger M; Toll L; Schmidhammer H; McLaughlin JP
Br J Pharmacol; 2017 Aug; 174(15):2444-2456. PubMed ID: 28494108
[TBL] [Abstract][Full Text] [Related]
33. Straub tail reaction in mice treated with σ(1) receptor antagonist in combination with methamphetamine.
Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Tanaka K; Nishiyama N; Takemura M
Brain Res; 2012 Oct; 1482():40-6. PubMed ID: 22981417
[TBL] [Abstract][Full Text] [Related]
34. Copaifera langsdorffii Desf. tree oleoresin-induced antinociception recruits µ
Santana VC; Marmentini BM; Cruz GG; de Jesus LC; Walicheski L; Beffa FH; Maffei THP; Streg RV; Veiga-Junior VF; Andrighetti CR; Freitas de Lima MC; de Sousa Valladão DM; de Oliveira RC; Neyra MOC; de Araújo Berber RC; Falconi-Sobrinho LL; Coimbra NC; de Oliveira R
Behav Brain Res; 2024 Mar; 461():114832. PubMed ID: 38142860
[TBL] [Abstract][Full Text] [Related]
35. Allosterism within
Jacobs BA; Pando MM; Jennings E; Chavera TA; Clarke WP; Berg KA
Mol Pharmacol; 2018 Apr; 93(4):376-386. PubMed ID: 29436492
[TBL] [Abstract][Full Text] [Related]
36. Opioids differentially modulate two synapses important for pain processing in the amygdala.
Kissiwaa SA; Patel SD; Winters BL; Bagley EE
Br J Pharmacol; 2020 Jan; 177(2):420-431. PubMed ID: 31596498
[TBL] [Abstract][Full Text] [Related]
37. Role of fosaprepitant, a neurokinin Type 1 receptor antagonist, in morphine-induced antinociception in rats.
Prasoon P; Gupta S; Kumar R; Gautam M; Kaler S; Ray SB
Indian J Pharmacol; 2016; 48(4):394-398. PubMed ID: 27756950
[TBL] [Abstract][Full Text] [Related]
38. A promising chemical series of positive allosteric modulators of the μ-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effects.
Pryce KD; Kang HJ; Sakloth F; Liu Y; Khan S; Toth K; Kapoor A; Nicolais A; Che T; Qin L; Bertherat F; Kaniskan HÜ; Jin J; Cameron MD; Roth BL; Zachariou V; Filizola M
Neuropharmacology; 2021 Sep; 195():108673. PubMed ID: 34153316
[TBL] [Abstract][Full Text] [Related]
39. Agonist-dependent development of delta opioid receptor tolerance in the colon.
DiCello JJ; Saito A; Rajasekhar P; Sebastian BW; McQuade RM; Gondin AB; Veldhuis NA; Canals M; Carbone SE; Poole DP
Cell Mol Life Sci; 2019 Aug; 76(15):3033-3050. PubMed ID: 30904952
[TBL] [Abstract][Full Text] [Related]
40. Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak.
Rossi GC; Bodnar RJ
Cell Mol Neurobiol; 2021 Jul; 41(5):863-897. PubMed ID: 32970288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]